四川首家生物制药企业成为“经核准出口商”

Core Points - Sichuan Debor Pharmaceutical Co., Ltd. has become the first "Approved Exporter" in the biopharmaceutical sector of Sichuan province, marking a significant step in the internationalization of the local biopharmaceutical industry [1] - The "Approved Exporter" system is a highlight of regional free trade agreements such as RCEP, allowing recognized companies to issue their own origin declarations without customs review, thus facilitating smoother and more cost-effective international trade [1] - The pharmaceutical and health industry is a key strategic emerging industry in Sichuan, with an expected overall scale exceeding 600 billion yuan in 2024 and over 600 large-scale industrial enterprises, including major players like Kelun, Baile, Beite, and Good Doctor [1] Industry Impact - The implementation of the "Approved Exporter" system and other facilitation measures is expected to accelerate the development of more export-oriented enterprises in Sichuan [1] - Currently, five companies in Sichuan have been recognized as "Approved Exporters," spanning key industries such as electronic information, chemicals, liquor, and biopharmaceuticals [1] - The customs authority plans to provide a comprehensive service chain to support the "Approved Exporter" system, enhancing the capabilities of Sichuan's foreign trade enterprises [1]